Comparison

Dofequidar fumarate European Partner

Item no. TMO-T11071-200mg
Manufacturer TargetMol
CASRN 153653-30-6
Amount 200 mg
Quantity options 100 mg 1 mL x 10 mM (in DMSO) 10 mg 1 mg 1 mL 200 mg 25 mg 2 mg 500 mg 50 mg 5 mg
Category
Type Inhibitor
Specific against other
Purity 0,9943
Formula C34H35N3O7
Smiles OC(=O)\C=C\C(O)=O.OC(COc1cccc2ncccc12)CN1CCN(CC1)C(=O)C(c1ccccc1)c1ccccc1
ECLASS 10.1 32160490
ECLASS 11.0 32160490
UNSPSC 12000000
Alias MS-209
Shipping condition Cool pack
Available
Manufacturer - Targets
P-gp
Shipping Temperature
cool pack
Storage Conditions
-20°
Molecular Weight
597, 66
Description
Dofequidar fumarate (MS-209)(MS-209 fumarate), a quinoline-based compound administered orally, is known for counteracting multidrug resistance (MDR) through the inhibition of ABCB1/P-glycoprotein (P-gp) and ABCC1/MDR-associated protein 1.
Bioactivity
Dofequidar fumarate(MS-209 fumarate), an orally active quinoline compound, has been reported to overcome MDR by inhibiting ABCB1/P-gp, ABCC1/MDR-associated protein 1.
Pathways
Membrane transporter/Ion channel|||Neuroscience

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 200 mg
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close